Needham & Company Maintains a 'Buy' on Dendreon (DNDN); ASCO Mtg Presentations Highlight PROVENGE Clinical Benefits Beyond Overall Survival

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Needham & Company Maintains a 'Buy' on Dendreon (DNDN); ASCO Mtg Presentations Highlight PROVENGE Clinical Benefits Beyond Overall Survival
Dendreon Corp (NASDAQ: DNDN) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High $3.46 
Open $11.75    52 Week Low $0.11 
Day High $0.13    P/E N/A 
Day Low $0.13    EPS $-1.63 
Volume 279